Russia’s health minister announced that the country is planning a mass vaccination campaign for October.
A state research center in Moscow, the Gamaleya Institute, has completed clinical trials of the vaccine and is working on its registration.
Health Minister Mikhail Murashko said, “We are planning more extensive vaccinations for October” after presenting his plan to give the vaccine to teachers and doctors first.
The Gamaleya Institute, a state research center in Moscow, has completed clinical trials of a potential vaccine that Russia plans to deploy in October
Health Minister Mikhail Murashko said doctors and teachers would receive vaccine first
Russia’s first potential vaccine is expected to be approved in August, unnamed sources told Reuters.
However, some experts have expressed concern that Russia is moving too fast in developing a vaccine, without ensuring that it is safe, in order to gain national prestige.
U.S. infectious disease expert Anthony Fauci said yesterday that the U.S. is unlikely to use a vaccine developed by Russia or China due to different regulatory systems.
He said during a congressional hearing: “I hope the Chinese and Russians actually test the vaccine before giving the vaccine to anyone. “
“Claims that a vaccine is ready to be distributed before testing is done, I think, are problematic at best.
Russia was also reportedly involved in hacking coronavirus research labs in the United States and the United Kingdom in May this year.
The US Agency for Cybersecurity and Infrastructure Security and the UK’s National Cyber Security Center did not name any countries, but Sky News said the culprits were China, Russia and Iran.
Russian Ambassador to the UK Andrei Kelin told the BBC he rejected the accusation.
The joint opinion said coronavirus research was targeted, as the first country to develop a vaccine will undoubtedly attain enormous diplomatic and geopolitical influence.
Countries around the world are in a race to create a vaccine with more than 20 currently in clinical trials.
According to data from the World Health Organization, at least four are in final stages three of the human trials, including three developed in China and one in Britain.
The UK has already ordered 100 million doses of a vaccine developed by the University of Oxford.